Your browser doesn't support javascript.
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study.
Pisaturo, Mariantonietta; Calò, Federica; Russo, Antonio; Camaioni, Clarissa; Giaccone, Agnese; Pinchera, Biagio; Gentile, Ivan; Simeone, Filomena; Iodice, Angelo; Maggi, Paolo; Coppola, Nicola.
  • Pisaturo M; Infectious Diseases Unit, Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Calò F; Infectious Diseases Unit, Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Russo A; Infectious Diseases Unit, Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Camaioni C; Infectious Diseases Unit, Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Giaccone A; Infectious Diseases Unit, Federico II University, Naples, Italy.
  • Pinchera B; Infectious Diseases Unit, Federico II University, Naples, Italy.
  • Gentile I; Infectious Diseases Unit, Federico II University, Naples, Italy.
  • Simeone F; Infectious Disease Unit, AORN Caserta, Caserta, Italy.
  • Iodice A; Infectious Disease Unit, AORN Caserta, Caserta, Italy.
  • Maggi P; Infectious Diseases Unit, Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Coppola N; Infectious Disease Unit, AORN Caserta, Caserta, Italy.
Front Aging Neurosci ; 13: 698184, 2021.
Article in English | MEDLINE | ID: covidwho-1288785
ABSTRACT

BACKGROUND:

The aim of the present study was to investigate the outcome of patients with SARS-CoV-2 infection and dementia. PATIENTS AND

METHODS:

In a multicenter, observational, 12 matched case-control study all 23 patients with a history of dementia, hospitalized with a diagnosis of SARS-CoV-2 infection from February 28th 2020 to January 31st 2021 were enrolled. For each Case, 2 patients without dementia observed in the same period study, pair matched for gender, age (±5 years), PaO2/FiO2 (P/F) ratio at admission (<200, or >200), number of comorbidities (±1; excluding dementia) were chosen (Control group).

RESULTS:

The majority of patients were males (60.9% of Cases and Controls) and very elderly [median age 82 years (IQR 75.5-85) in the Cases and 80 (IQR 75.5-83.75) in the Controls]. The prevalence of co-pathologies was very high all the Cases and 43 (93.5%) Controls showed a Charlson comorbidity index of at least 2. During hospitalization the patients in the Case group less frequently had a moderate disease of COVID-19 (35 vs. 67.4%, p = 0.02), more frequently a severe disease (48 vs. 22%, p = 0.03) and more frequently died (48 vs. 22%, p = 0.03). Moreover, during coronavirus disease 2019 (COVID-19), 14 (60.8%) patients in the Case group and 1 (2.1%; p < 0.000) in the Control group showed signs and symptoms of delirium.

CONCLUSION:

Patients with dementia are vulnerable and have an increased risk of a severe disease and death when infected with COVID-19.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study Language: English Journal: Front Aging Neurosci Year: 2021 Document Type: Article Affiliation country: Fnagi.2021.698184

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study Language: English Journal: Front Aging Neurosci Year: 2021 Document Type: Article Affiliation country: Fnagi.2021.698184